BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29659909)

  • 1. Sexually Transmitted Bedfellows: Exquisite Association Between HIV and Herpes Simplex Virus Type 2 in 21 Communities in Southern Africa in the HIV Prevention Trials Network 071 (PopART) Study.
    Bradley J; Floyd S; Piwowar-Manning E; Laeyendecker O; Young A; Bell-Mandla N; Bwalya J; Bock P; Fidler S; Ayles H; Hayes RJ;
    J Infect Dis; 2018 Jul; 218(3):443-452. PubMed ID: 29659909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania.
    del Mar Pujades Rodríguez M; Obasi A; Mosha F; Todd J; Brown D; Changalucha J; Mabey D; Ross D; Grosskurth H; Hayes R
    AIDS; 2002 Feb; 16(3):451-62. PubMed ID: 11834958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of herpes simplex virus type 2 in different risk groups: thirty years after the onset of HIV.
    Reinheimer C; Doerr HW
    Intervirology; 2012; 55(6):395-400. PubMed ID: 22538395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations.
    Weiss HA; Buvé A; Robinson NJ; Van Dyck E; Kahindo M; Anagonou S; Musonda R; Zekeng L; Morison L; Caraël M; Laga M; Hayes RJ;
    AIDS; 2001 Aug; 15 Suppl 4():S97-108. PubMed ID: 11686471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR
    Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control.
    Korr G; Thamm M; Czogiel I; Poethko-Mueller C; Bremer V; Jansen K
    BMC Infect Dis; 2017 Jul; 17(1):471. PubMed ID: 28683784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
    Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H;
    PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of universal testing and treatment on sexual risk behaviour and herpes simplex virus type 2: a prespecified secondary outcomes analysis of the HPTN 071 (PopART) community-randomised trial.
    Wilson E; Donnell D; Skalland T; Floyd S; Moore A; Bell-Mandla N; Bwalya J; Kasese N; Dunbar R; Shanaube K; Kosloff B; Laeyendecker O; Agyei Y; Hoddinott G; Bock P; Fidler S; Hayes R; Ayles H;
    Lancet HIV; 2022 Nov; 9(11):e760-e770. PubMed ID: 36332653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa.
    Freeman EE; White RG; Bakker R; Orroth KK; Weiss HA; Buvé A; Hayes RJ; Glynn JR
    Vaccine; 2009 Feb; 27(6):940-6. PubMed ID: 19071187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing herpes simplex virus type 2 infection among females in Enugu, Enugu State, Nigeria.
    Ojinmah UR; Ozoh GA; Onyekonwu CL
    Niger J Med; 2014; 23(2):130-41. PubMed ID: 24956686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can combination prevention strategies reduce HIV transmission in generalized epidemic settings in Africa? The HPTN 071 (PopART) study plan in South Africa and Zambia.
    Vermund SH; Fidler SJ; Ayles H; Beyers N; Hayes RJ
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S221-7. PubMed ID: 23764639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection.
    Auvert B; Buvé A; Ferry B; Caraël M; Morison L; Lagarde E; Robinson NJ; Kahindo M; Chege J; Rutenberg N; Musonda R; Laourou M; Akam E;
    AIDS; 2001 Aug; 15 Suppl 4():S15-30. PubMed ID: 11686462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and correlates of herpes simplex virus type-2 infection among men who have sex with men, san francisco, 2008.
    Bohl DD; Katz KA; Bernstein K; Wong E; Raymond HF; Klausner JD; McFarland W
    Sex Transm Dis; 2011 Jul; 38(7):617-21. PubMed ID: 21278625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection.
    Chen CY; Ballard RC; Beck-Sague CM; Dangor Y; Radebe F; Schmid S; Weiss JB; Tshabalala V; Fehler G; Htun Y; Morse SA
    Sex Transm Dis; 2000 Jan; 27(1):21-9. PubMed ID: 10654864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-disparate partnerships and HSV-2 among adolescent girls and young women in South Africa: implications for HIV infection risk.
    Maughan-Brown B; George G; Beckett S; Evans M; Lewis L; Cawood C; Khanyile D; Kharsany ABM
    Sex Transm Infect; 2019 Sep; 95(6):443-448. PubMed ID: 30737260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of herpes simplex virus type 2 infection, human immunodeficiency virus/herpes simplex virus type 2 coinfection, and associated risk factors in a national, population-based survey in Kenya.
    Mugo N; Dadabhai SS; Bunnell R; Williamson J; Bennett E; Baya I; Akinyi N; Mohamed I; Kaiser R
    Sex Transm Dis; 2011 Nov; 38(11):1059-66. PubMed ID: 21992985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of herpes simplex virus (HSV)- type 2 co-infection among HIV-positive women in Ukraine, but no increased HIV mother-to-child transmission risk.
    Aebi-Popp K; Bailey H; Malyuta R; Volokha A; Thorne C;
    BMC Pregnancy Childbirth; 2016 Apr; 16():94. PubMed ID: 27121953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilevel Gender-Equitable Norms and Risk of HIV and Herpes Simplex Virus Type 2 Acquisition Among Young South African Women: A Longitudinal Analysis of the HIV Prevention Trials Network 068 Cohort.
    Wesson P; Lippman SA; Neilands TB; Twine R; Ahern J; Gómez-Olivé FX; Peacock D; MacPhail C; Kahn K; Pettifor A
    J Adolesc Health; 2019 Dec; 65(6):730-737. PubMed ID: 31543406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
    Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
    AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.